Improving health and making technological contributions to change human life
  • 2009
    Established in 2009
  • 30
    More than 30 inventions
  • 300
    More than 300 employees
  • Anhui Lianchuang Biological Medicine Co., Ltd ( hereinafter referred to as "The Company" ), was established in 2009 and headquartered in the west of Fanhua Avenue, Hefei Economic and Technological Development Zone. The company is a national high-tech enterprise with the mission of serving health and pursuing technical contribution. It is an innovative technology company providing products and technical services to consumers and global pharmaceutical manufacturers.

    The company's current main business is pharmaceutical APIs and characteristic intermediates.

    The company has several subsidiaries, which are engaged in the R&D and production of pharmaceutical APIs and intermediates, preparations MAH, diabetes control devices and food development, etc.

    After years of development, the company has gathered a group of professional scientific experts and business backbone, specializing in the field of organic synthesis and enzymatic synthesis of pharmaceutical products. Nowadays, the company has more than 20 independent innovation invention patents, and has provided products and technical support for nearly 100 enterprises worldwide, forming a product line with diabetes control drugs as the core and other complementary products.

    The company always advocates innovation and sharing drive in parallel -- in innovation development, the company implements active and flexible business model and differentiated product selection; in operation strategy, the company insists on the principle of maximizing corporate value, making the company a platform for customers and employees to discuss, share, build and win together.

    Anhui Lianchuang Biological Medicine Co., Ltd will not forget its original intention, run true to form, to promote technological innovation and contribute to building a healthy China.

    Anhui Lianchuang Biological Medicine Co.,Ltd
    development history

    The production base of Anhui Senji Pharmaceutical Co., Ltd. has been completed and put into operation

    Selected as a backup enterprise for listing in Anhui Province

    Mr. Ge Depei, Chairman, was selected as one of the "seventh batch of top professional and technical talents in Feixi County"


    Awarded the "9th Anhui Provincial Patent Award (Excellent Award)"

    Won the "2022 Hefei Labor Harmony Unit"

    Mr. Ge Depei, Chairman of the Board of Directors, was awarded "Hefei High level Talents"

    General Manager Dr. Wu Qihua was awarded "Hefei High level Talents"


    Awarded as a "specialized, refined, and innovative" small and medium-sized enterprise in Anhui Province

    Re evaluation of "high-tech enterprises"

    Successfully completed round A financing


    Establishment of subsidiary Anhui Senji Pharmaceutical Co., Ltd

    "Technical R&D team of drugs for the treatment of type II diabetes" was selected as Luzhou Industrial Innovation Team in 2019

    Dr. Wu Qihua, General Manager, was awarded the title of "Leader of Luzhou Industrial Innovation Team"


    Hefei "Specialized, Special and New" SMEs in 2018

    2019 Anhui Province New Product (Fourth Batch) Three Recognition

    Dr. Wu Qihua, General Manager, was awarded the title of "Innovation Talent of Luzhou"


    Acquisition of production base Huainan Lianke Biopharmaceutical Co., Ltd

    Re evaluation of "high-tech enterprises"

    Dr. Wu Qihua, General Manager, was awarded the title of "Innovative Talent of Feixi"


    "2017 Hefei Intellectual Property Management Standardized Enterprise"

    Dr. Wu Qihua, General Manager, was awarded the "Eighth Batch of Top Professional and Technical Talents in Hefei"


    The subsidiary Maitian Biology settled in Hefei High tech Zone, focusing on Biocatalysis technology research

    Recognized as "Hefei diabetes API Engineering Technology Research Center"

    Won the "2016 Hefei Intellectual Property Demonstration Enterprise"

    Mr. Ge Depei, Chairman, was awarded the "Anhui Special Support Plan" Innovation and Entrepreneurship Leading Talent (Second Batch)


    Ten new diabetes drugs, including kagliflozin and Dapagliflozin, have been approved for clinical approval

    Awarded as a "High tech Enterprise"

    "Diabetes new target drug SGLT2 inhibitor technology research and development team" was selected as the "535" innovation and entrepreneurship team in Feixi County in 2015

    Dr. Wu Qihua, General Manager, was awarded the title of "Anhui Province's Leading Technology Talent" and "Feixi County's Leading Talent in 2015"


    Completed the shareholding system transformation and renamed Anhui Lianchuang Biopharmaceutical Co., Ltd

    Listing of Anhui Provincial Equity Custody Trading Center


    Preparation method and crystal preparation patent authorization of SGLT2 inhibitor


    Trademark approved for registration


    Purchase and put into use a new drug research and development office building


    Anhui Lianchuang Medicinal chemistry Co., Ltd. was established

    Home Product News Contact